Milrinone comment watch save
BreastfeedingPediatric

  • TRADE NAME: Primacor (Sanofi-Aventis)
  • INDICATIONS: Severe congestive heart failure unresponsive to conventional maintenance therapy; acute heart failure, including low output states following cardiac surgery.
  • CLASS: Phosphodiesterase inhibitor
  • HALF-LIFE: 2.3 hours
  • CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
    Anagrelide

Please login to view the rest of this drug profile.

Page last updated 07/31/2023

Symbol key

Incidence

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness

Hospitalization possible
Life threatening
Fatal

Warnings in other populations

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric

Back to top